SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today that it entered into an amendment of the lease with a subsidiary of Green Leaf Medical, LLC (Green Leaf) at 135 Horton Drive in…
Details
TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide (PEA), or FSD201. This single-site study was conducted at the Alfred Hospital, part of the Alfred Health group of hospitals serving the state of…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs is pleased to announce an update on the Company’s edibles product launch and expansion plan in California and Oregon to capitalize on segment growth. According to BDS Analytics, edibles spending in the US and Canada is forecast to grow to more than $4.1 billion by 2022. In California, ingestibles generated $44 million…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces that it will host a conference call on Wednesday, June 24, 2020 to discuss Q1 2020 financial and operational results. Conference Call Details Investors can call in and Q&A with Kiran Sidhu, the Chief Executive Officer, and Philip Van…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced its financial and operational results for the three months ended March 31, 2020. Revenue for the three months ended March 31, 2020 were $4,449,098, a 49% decrease compared to $8,718,503 in the three months ended March 31, 2019. Revenues…
Details
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announced the issuance of 12,043,924 common shares of the Company to certain independent consultants, related parties, and suppliers of the Company, in lieu of cash consideration (the “Compensation Shares”) at a price of C$0.10 per Compensation Share, being the closing…
Details
NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today announced the expected completion of the second tranche of its previously announced US$50.0 million financing with the offering of an aggregate principal amount of US$15.7 million in 5.00% senior secured convertible notes due 2023 (the “Convertible…
Details
DUBLIN–(BUSINESS WIRE)–The “Ethical Fashion Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering. This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places…
Details
PORTLAND, Ore.–(BUSINESS WIRE)–Lazarus Naturals, makers of effective, affordable CBD products, and one of the Pacific Northwest’s largest hemp-derived CBD producers, is disputing the CBD industry on its widespread belief that price determines quality of a CBD brand. The company announced today that it has implemented a price reduction of 20 to 40 percent for many…
Details
DENVER–(BUSINESS WIRE)–Green Dragon, a leading Colorado dispensary retailer, recently opened two new stores in the Denver Metro Area: The Boulder and the Cherry Creek neighborhoods of Denver. Green Dragon’s Boulder store, formerly Boulder Botanics, is located at 1750 30th St., serving the bustling commercial area surrounding the Crossroads Shopping Center. The Cherry Creek location, formerly…
Details
AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Tacrolimus Inhalation Powder for prophylaxis of lung allograft rejection. Tacrolimus…
Details
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc. today announced that the Health Science Authority (HSA) of Singapore has authorized reSET® for the treatment of adults with substance use disorder (SUD) in that country. This is the first time the HSA has authorized a prescription digital therapeutic (PDT) with claims to treat disease and/or improve clinical…
Details